Non-exclusive rebate agreement for olanzapine medicines

Summary

The tender concerns the conclusion of a non-exclusive rebate agreement for medicines containing olanzapine for the period from 01 September 2026 to 31 August 2028, with an option to extend the contract once for 12 months. This is a supply tender for medicines, and DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The bidder should note that the agreement will end automatically when an exclusive contract enters into force.